1. Yuan, Jingsheng, Lv, Tao, Yang, Jian, Yang, Jiayin, Shi, Yujun. 2022. HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma. In Redox biology, 58, 102546. doi:10.1016/j.redox.2022.102546. https://pubmed.ncbi.nlm.nih.gov/36423520/
2. Zinnall, Ulrike, Milek, Miha, Minia, Igor, Selbach, Matthias, Landthaler, Markus. 2022. HDLBP binds ER-targeted mRNAs by multivalent interactions to promote protein synthesis of transmembrane and secreted proteins. In Nature communications, 13, 2727. doi:10.1038/s41467-022-30322-7. https://pubmed.ncbi.nlm.nih.gov/35585045/
3. Yuan, Jingsheng, Lv, Tao, Yang, Jian, Shi, Yujun, Jiang, Li. 2022. The lipid transporter HDLBP promotes hepatocellular carcinoma metastasis through BRAF-dependent epithelial-mesenchymal transition. In Cancer letters, 549, 215921. doi:10.1016/j.canlet.2022.215921. https://pubmed.ncbi.nlm.nih.gov/36122630/
4. Kosmas, Kosmas, Filippakis, Harilaos, Khabibullin, Damir, Anderson, Paul J, Henske, Elizabeth P. 2021. TSC2 Interacts with HDLBP/Vigilin and Regulates Stress Granule Formation. In Molecular cancer research : MCR, 19, 1389-1397. doi:10.1158/1541-7786.MCR-20-1046. https://pubmed.ncbi.nlm.nih.gov/33888601/
5. Cha, Kihoon, Li, Yi, Yi, Gwan-Su. 2016. Discovering gene expression signatures responding to tyrosine kinase inhibitor treatment in chronic myeloid leukemia. In BMC medical genomics, 9 Suppl 1, 29. doi:10.1186/s12920-016-0194-5. https://pubmed.ncbi.nlm.nih.gov/27534394/
6. Xia, Rong, Tang, Hua, Shen, Jiemiao, Yang, Jinyou, Wang, Chao. 2021. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population. In Cancer cell international, 21, 154. doi:10.1186/s12935-021-01857-4. https://pubmed.ncbi.nlm.nih.gov/33663535/
7. Otsuka, Hiroko, Gotoh, Yoshitaka, Komeno, Takashi, Akiyama, Hirotada, Tashiro, Fumio. 2014. Aralin, a type II ribosome-inactivating protein from Aralia elata, exhibits selective anticancer activity through the processed form of a 110-kDa high-density lipoprotein-binding protein: a promising anticancer drug. In Biochemical and biophysical research communications, 453, 117-23. doi:10.1016/j.bbrc.2014.09.067. https://pubmed.ncbi.nlm.nih.gov/25261720/
8. Iwata-Otsubo, Aiko, Darr, Kahlen R, Torres-Martinez, Wilfredo, Hodge, Jennelle C. 2022. Genotype-Phenotype Correlation of Distal 2q37 Deletions. In Cytogenetic and genome research, 162, 237-243. doi:10.1159/000526660. https://pubmed.ncbi.nlm.nih.gov/36516793/